Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Vertex Pharmaceuticals Limited by Year
Vertex Pharmaceuticals (Europe) Limited (UK 02907620) — Net assets / Total equity ($M) ($M)
Vertex Pharmaceuticals Vertex Pharmaceuticals Limited: $4,764M in FY2025, up 10.9% from a year earlier. That is the highest of the 8 years on record here.
Where the FY2025 figure comes from
“Total shareholder's funds 4,763,933 4,295,044”
Source: Vertex Pharmaceuticals (Europe) Limited (02907620) ↗
Reported in UK Companies House Audited Statutory Financial Statements (02907620, FY2018–FY2025, OCR).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Vertex Pharmaceuticals (Europe) Limited (UK 02907620) — Net assets / Total equity ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,764 | +10.9% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2024 | Dec 31, 2024 | 4,295 | +15.2% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2023 | Dec 31, 2023 | 3,729 | +9.6% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2022 | Dec 31, 2022 | 3,402 | +14.3% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2021 | Dec 31, 2021 | 2,977 | +12.9% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2020 | Dec 31, 2020 | 2,636 | +181.4% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2019 | Dec 31, 2019 | 937 | +15.8% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2018 | Dec 31, 2018 | 809 | – | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
Breakdown
What makes up vertex Pharmaceuticals Limited
- Vertex Europe (UK) — Total non-current / fixed assets ($M)1,734 · FY2025
- Vertex Europe (UK) — Total current assets ($M)4,706 · FY2025
- Vertex Europe (UK) — Creditors: amounts falling due within one year ($M)1,551 · FY2025
- Vertex Europe (UK) — Total non-current liabilities ($M)126 · FY2025
- Vertex Europe (UK) — Retained earnings / Profit and loss account ($M)2,152 · FY2025
Cite this data
StockData. (2026). Vertex Pharmaceuticals Vertex Pharmaceuticals Limited ($M), annual FY2018–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/uk-eur-net-assets
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.